-
Patent Agency Ranking
公开(公告)号：KR102049522B1
公开(公告)日：2019-11-27
申请号：KR1020180065038
申请日：2018-06-05
Applicant: 충남대학교산학협력단
IPC: A61K31/197 , A23L33/10 , A61P31/00
-
公开(公告)号：KR102049526B1
公开(公告)日：2019-11-27
申请号：KR1020180065040
申请日：2018-06-05
Applicant: 충남대학교산학협력단
IPC: A61K31/197 , A23L33/10 , A61P31/06
-
公开(公告)号：KR101476781B1
公开(公告)日：2014-12-29
申请号：KR1020140055398
申请日：2014-05-09
Applicant: 충남대학교산학협력단
CPC classification number: C12Q1/689 , C12Q2600/178
Abstract: The present invention relates to microRNA (hereinafter, ″miRNA″) which can be used as a biomarker for diagnosing tuberculosis and a tuberculosis diagnosing kit which can measure the expressed amount of the same. More specifically, the present invention relates to a tuberculosis diagnosing biomarker and a tuberculosis diagnosing kit which can measure the expressed amount of the same, wherein the tuberculosis diagnosing biomarker consists of miRNA-17-5p (sequence number 1) and has increased expression due to tuberculosis infection.
Abstract translation: 本发明涉及可用作诊断结核病的生物标志物的微小RNA（以下称为“miRNA”）和可以测量其表达量的结核病诊断试剂盒。 更具体地，本发明涉及可以测量其表达量的结核病诊断生物标志物和结核病诊断试剂盒，其中结核病诊断生物标志物由miRNA-17-5p（序列号1）组成，并且由于 结核病感染
-
公开(公告)号：KR20180044667A
公开(公告)日：2018-05-03
申请号：KR20160138467
申请日：2016-10-24
Applicant: 충남대학교산학협력단
IPC: C12Q1/68
CPC classification number: C12Q1/6883 , C12Q1/6886 , C12Q2600/136 , C12Q2600/178
Abstract: 본발명은마이크로 RNA를마커로이용한자가포식조절제의스크리닝방법에관한것으로, 보다상세하게는 (A) miRNA-144를발현하는세포또는조직에시험물질을처리하는단계; 및 (B) 상기시험물질이처리된세포또는조직에서 miRNA-144의발현을측정하는단계; 및 (C) 상기 (B) 단계에서측정된 miRNA-144의발현수준이시험물질을처리하지않은대조군에비해변화된경우자가포식조절제로판정하는단계;를포함하는것을특징으로하는자가포식조절제의스크리닝방법에관한것이다.
-
公开(公告)号：KR101893387B1
公开(公告)日：2018-08-30
申请号：KR1020160138467
申请日：2016-10-24
Applicant: 충남대학교산학협력단
IPC: C12Q1/68
Abstract: 본발명은마이크로 RNA를마커로이용한자가포식조절제의스크리닝방법에관한것으로, 보다상세하게는 (A) miRNA-144를발현하는세포또는조직에시험물질을처리하는단계; 및 (B) 상기시험물질이처리된세포또는조직에서 miRNA-144의발현을측정하는단계; 및 (C) 상기 (B) 단계에서측정된 miRNA-144의발현수준이시험물질을처리하지않은대조군에비해변화된경우자가포식조절제로판정하는단계;를포함하는것을특징으로하는자가포식조절제의스크리닝방법에관한것이다.
-
-
-
-
Search Results
5
records
(took 0.02 seconds)
